Long COVID Is Being Erased—Again
What was once outright denial has morphed into a subtler dismissal. In this article published by the Atlantic,…
Symptom persistence and biomarkers in post-COVID-19/chronic fatigue syndrome – results from a prospective observational cohort
New study assessed symptom severity and various biomarkers at three time points post infection (3-8 months, 9-16 months,…
Hope for long COVID treatment breakthrough after study’s ‘really positive’ findings
The results of a new study, published in the Lancet eClinical Medicine, showed that an experimental drug (AXA1125) significantly reduces…
Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI
A study recently published by Scientific Reports (Nature) identified a significative alteration of cerebral perfusion pattern in post-COVID-19…
Ask the Expert webinar: Long COVID (Wednesday 10 May, 7pm – 8pm BST)
Save the date! Wednesday 10 May 7pm-8pm BST The public are invited to a free webinar to ask…
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term NeurologicalComplications in post-COVID-19
A recent study led by Ali Ertürk (Director at Helmholtz Munich, Full Professor at LMU Munich) shows that…
The 1st Long COVID Newsletter is coming soon!
Do not miss the chance to learn more about the project’s updates for the past months. You can…
Cellular and molecular biomarkers of long COVID: a scoping review
This review, published by the Lancet, was conducted using the Joanna Briggs Institute (JBI) Methodology for Scoping Reviews….